Literature DB >> 28771972

A new insight into CFTR allele frequency in Brazil through next generation sequencing.

Luisa M Nunes1, Roberto Ribeiro2, Vivian D T Niewiadonski3, Ester Sabino2, Guilherme L Yamamoto4, Débora R Bertola4, Nelson Gaburo3, Luiz Vicente R F da Silva Filho1,4.   

Abstract

BACKGROUND: As of 2013, fewer than 20% of patients in the Brazilian CF Registry had two CFTR mutations identified. The aim of this study was to sequence the coding region of the CFTR in Brazilian CF patients and determine the frequency of mutations in this cohort.
METHODS: Patients with CF and those with suspected atypical CF or CFTR-related disorders were invited to enroll. Total DNA was extracted from blood samples, quantified, and purified. Library preparation was performed using Ion Xpress™ Plus gDNA and Amplicon Library preparation kits (Life Technologies), as well as sequencing using the Ion Torrent platform (Life Technologies).
RESULTS: A total of 141 patients were enrolled, and 45 mutations were identified. Among 126 CF patients, we identified mutations in 97.2% of alleles. The three most common mutations were F508del, G542X, and 3120 + 1G->A. Five novel pathogenic mutations were also identified.
CONCLUSIONS: Next generation sequencing (NGS) allowed the identification of mutations in most CF alleles and confirmed allelic heterogeneity in our population.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  cystic fibrosis; cystic fibrosis transmembrane regulator; next generation sequencing

Mesh:

Substances:

Year:  2017        PMID: 28771972     DOI: 10.1002/ppul.23774

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  2 in total

1.  Next-generation sequencing for identifying a novel/de novo pathogenic variant in a Mexican patient with cystic fibrosis: a case report.

Authors:  Angélica Martínez-Hernández; Julieta Larrosa; Francisco Barajas-Olmos; Humberto García-Ortíz; Elvia C Mendoza-Caamal; Cecilia Contreras-Cubas; Elaheh Mirzaeicheshmeh; José Luis Lezana; Lorena Orozco
Journal:  BMC Med Genomics       Date:  2019-05-22       Impact factor: 3.063

2.  Novel, rare and common pathogenic variants in the CFTR gene screened by high-throughput sequencing technology and predicted by in silico tools.

Authors:  Stéphanie Villa-Nova Pereira; José Dirceu Ribeiro; Antônio Fernando Ribeiro; Carmen Sílvia Bertuzzo; Fernando Augusto Lima Marson
Journal:  Sci Rep       Date:  2019-04-17       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.